Advertisement
U.S. markets open in 4 hours 1 minute
  • S&P Futures

    5,303.00
    -5.25 (-0.10%)
     
  • Dow Futures

    40,134.00
    -10.00 (-0.02%)
     
  • Nasdaq Futures

    18,474.00
    -29.75 (-0.16%)
     
  • Russell 2000 Futures

    2,133.10
    -5.30 (-0.25%)
     
  • Crude Oil

    81.61
    +0.26 (+0.32%)
     
  • Gold

    2,215.70
    +3.00 (+0.14%)
     
  • Silver

    24.54
    -0.21 (-0.86%)
     
  • EUR/USD

    1.0783
    -0.0047 (-0.43%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    12.96
    +0.18 (+1.41%)
     
  • GBP/USD

    1.2590
    -0.0048 (-0.38%)
     
  • USD/JPY

    151.4380
    +0.1920 (+0.13%)
     
  • Bitcoin USD

    70,691.58
    +932.50 (+1.34%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,960.40
    +28.42 (+0.36%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Why Relay Therapeutics Is Up 30% This Week

Why Relay Therapeutics Is Up 30% This Week

What happened Shares of Relay Therapeutics (NASDAQ: RLAY), a clinical-stage biopharmaceutical company, have risen about 30% since the stock's closing price last Friday. Investors are highly encouraged by interim clinical trial data that suggest the company's new approach to drug development can produce a new blockbuster cancer treatment.

Advertisement